WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

NMPA Solicits Public Comments on Drug Contract Manufacturing Document In order to strengthen the supervision and management of pharmaceutical contract manufacture and promote the high-quality development of the pharmaceutical industry, the ...
(11/5/2024)

China Biotech and the Bear: A Perspective (Bio... (11/11/2024)

Trump’s Trade Tango Returns: Will China’s Bi... (11/11/2024)

China Biopharma Tracker – October 2024 (Pharm... (11/11/2024)

Stimulus Package vs. Drug Price Negotiation, I... (11/7/2024)

Landmark Whistleblower Program for China's Hea... (11/5/2024)

Big Pharma Doubles Down on China (The Wire Chi... (11/4/2024)

How AstraZeneca Bilked China's Insurance Progr... (11/4/2024)

Probe of AstraZeneca Executive in China Raises... (11/4/2024)

China Investigation of Drug Firm Exec Deals La... (10/31/2024)

AstraZeneca's China Legal Woes Follow Push For... (10/31/2024)

China's Compliance Guidelines for Healthcare C... (10/30/2024)

VCs Move to Launch U.S.-Based Companies to Adv... (10/29/2024)

Biocytogen Announces IDEAYA's Nomination... (11/12/2024) China to Launch Pilot Programme for Virt... (11/11/2024) Codone Biotech Becomes Bayer Co.Lab's Fi... (11/11/2024) Chiesi Drives Innovation and Sustainabil... (11/11/2024) NHSA and MOF Jointly Issue the Notice on... (11/11/2024) Kanglin Biotec Secures 150 Million RMB i... (11/11/2024) Dizal Submits NDA to FDA for Sunvozertin... (11/11/2024) China Approves Second KRAS-G12C Inhibito... (11/11/2024) Precision Bio's CD19-Targeted CAR-T Ther... (11/11/2024) Alphamab Reports Results of FIH Clinical... (11/11/2024) Recent Executive Moves (11/8/2024) Bayer China Launches OPERA 2.0 Healthcar... (11/8/2024) AstraZeneca Clarifies: Investigation int... (11/8/2024) Ping An Health and Medtronic Form Strate... (11/8/2024) Pfizer Ignite Partners with Beijing Mabw... (11/8/2024) Nuwacell Secures CNY 150M in First Close... (11/8/2024) Junshi Reports on Phase II Trial of Tori... (11/8/2024) Cathay Innovation Partners with Sanofi t... (11/8/2024)

SMEI: Chinese Terminal Drug Market Fell 1.9% in H1/2024... Nine Pharma MNCs Grew Their Combined China Revenue at 1... Data Review: Chinese Drug Market 2016-2023 Review of Online Drug Sales Growth in China 2021-2023 Mainland China's Pharmaceutical Sales to Reach $345B by...

Biocytogen Announces IDEAYA's Nomination of Development... Kanglin Biotec Secures 150 Million RMB in Series A Fina... Chiesi Drives Innovation and Sustainability in Sino-Ita... Codone Biotech Becomes Bayer Co.Lab's First Resident in... China to Launch Pilot Programme for Virtual Primary Car...

CDE Issues the Notice on the Technical Requirements for... NMPA Solicits Public Comments on Drug Contract Manufact... NMPA Signs Letter of Intent on Cooperation with Danish ... Li Li Meets with Head of Brazil's Health Regulatory Age... NMPA Issues Announcement for Applicability of ICH Guide...

NHSA and MOF Jointly Issue the Notice on Prepayment of ... The 10th Round of National Level VBP of Drugs Officiall... NHC Minister Engages in Video Conference with WHO Direc... China's BMI Negotiation Spotlight Record Number of Orp... Innovative Drugs Lead the 2024 Health Insurance Price N...

China Targets AstraZeneca in BMI Fraud Probe over Tagri... AstraZeneca China President Under Investigation Amid Br... BeiGene Executive Under Investigation in China Amid Scr... Rouse: China's Rapid Rise in Global Innovation Strength... Aadi Bio Wins Arbitration, Rejecting Multimillion-Dolla...

Aurobindo Challenges China in the Global Penicillin G M... India Mulls New PLI Scheme to Reduce Chinese API Depend... FDA Criticizes Chinese API Producer for Deceptive Pract... US Urges Indian Pharma to Distance from China for APIs ... Chinese Researchers Makes Breakthrough with Paclitaxel ...

Alphamab Reports Results of FIH Clinical Study of Anti-... Precision Bio's CD19-Targeted CAR-T Therapy, pCAR-19B, ... China Approves Second KRAS-G12C Inhibitor, Garsorasib, ... Dizal Submits NDA to FDA for Sunvozertinib in EGFR Exon... Takeda Initiates Phase 3 Trials in China for Sleep Diso...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...